Skip to main content
. 2024 Oct 11;15:8817. doi: 10.1038/s41467-024-53236-y

Table 3.

Number, rate, and age-standardised rate for CVD deaths attributable to high FPG by specific causes and sex in China, 2010–2018 (95%UI)

2010 2018
Deaths (thousands) Mortality rate per 100,000 Age-standardised mortality rate (95% UI), per 100,000 Deaths (thousands) Mortality rate per100,000 Age-standardised mortality rate (95% UI), per 100,000
CVD
Total 352.80 (328.69–378.44) 40.80 (38.02–43.77) 40.80 (38.02–43.77) 498.61 (463.93–534.12) 53.02 (49.33–56.79) 42.56 (39.86–45.33)
Male 200.26 (186.05–216.35) 45.81 (42.56–49.49) 48.36 (44.68–52.58) 278.43 (257.99–300.08) 58.85 (54.53–63.43) 51.13 (47.44–54.99)
Female 152.62 (134.58–172.26) 35.70 (31.48–40.30) 32.98 (29.35–36.91) 220.59 (194.21–250.18) 47.20 (41.56–53.53) 33.88 (30.40–37.79)
Ischaemic heart disease
Total 166.12 (150.43–182.66) 19.21 (17.40–21.13) 19.21 (17.40–21.13) 247.12 (224.01–272.48) 26.28 (23.82–28.97) 20.91 (19.15–22.82)
Male 90.38 (82.31–99.93) 20.68 (18.83–22.86) 22.04 (19.83–24.55) 132.18 (119.79–146.36) 27.94 (25.32–30.94) 24.36 (22.13–26.90)
Female 75.04 (62.30–89.37) 17.55 (14.57–20.91) 16.03 (13.47–18.85) 114.72 (96.34–137.48) 24.55 (20.61–29.42) 17.28 (14.83–20.27)
Ischaemic stroke
Total 83.72(75.23–93.19) 9.68(8.70–10.78) 9.68 (8.70–10.78) 135.83 (121.17–151.16) 14.44 (12.88–16.07) 11.34 (10.22–12.55)
Male 46.92(41.91–52.51) 10.73(9.59–12.01) 11.45 (10.17–12.97) 75.87 (67.46–85.73) 16.04 (14.26–18.12) 13.65 (12.13–15.41)
Female 36.78(30.45–44.18) 8.60(7.12–10.33) 7.92 (6.66–9.40) 59.92 (49.42–71.36) 12.82 (10.57–15.27) 9.08 (7.66–10.61)
Haemorrhagic stroke
Total 103.29(96.91–109.75) 11.95(11.21–12.69) 11.95(11.21–12.69) 115.36(108.74–122.35) 12.27 (11.56–13.01) 10.26 (9.74–10.83)
Male 62.87(58.20–67.50) 14.38(13.31–15.44) 14.91(13.78–16.05) 70.06(65.57–74.99) 14.81 (13.86–15.85) 13.06 (12.25–13.95)
Female 40.26(36.12–45.40) 9.42(8.45–10.62) 8.94(8.10–9.98) 45.18(40.68–50.21) 9.67 (8.70–10.74) 7.46 (6.83–8.14)

CVD cardiovascular disease, FPG fasting plasma glucose, 95% UI 95% uncertainty intervals.